Description
You will lead health technology assessment (HTA) and evidence synthesis activities to support access and reimbursement in Japan. You will work with cross-functional colleagues in market access, clinical development, regulatory, and global HEOR teams.
Responsibilities:
- Lead and deliver evidence synthesis projects, including systematic literature reviews, targeted reviews, and meta-analyses to support HTA and economic models.
- Manage development and submission of Japan HTA dossiers, aligning strategy with internal stakeholders and local requirements.
- Design and oversee health economic analyses and support pricing and cost-effectiveness discussions.
- Coordinate cross-functional teams and external vendors to deliver studies on time, on budget, and to quality standards.
- Monitor HTA policy and stakeholder landscape in Japan and translate insights into proactive evidence plans.
- Prepare clear, concise outputs for internal and external audiences, including technical reports, presentations and manuscripts.
Basic Qualifications:
- Master's degree or higher in health economics, pharmacoepidemiology, public health, epidemiology, biostatistics, pharmacy, or related discipline.
- At least 3 years of relevant experience in HEOR, HTA submissions, real-world evidence, or market access in Japan.
- Demonstrated experience in conducting evidence synthesis (SLRs, meta-analysis) and applying results to HTA and models.
- Practical knowledge of Japan healthcare, reimbursement and HTA processes.
- Strong project management skills, including managing timelines, budgets, vendors and multiple stakeholders.
- Fluent Japanese and strong English communication skills, written and verbal.
This role is hybrid, based in Japan with a mix of office and remote work. Occasional travel within Japan and regionally may be required.